If you have a history of pancreatitis, kidney disease, or other health conditions, speak with your healthcare provider to determine if Zepbound is the right option for you
Our lead program, the first out of 45+ programs we are running and with 32 developmental candidates nominated in the past 6 years, began with an aging-informed, AI-discovered novel target that has never been in clinical trial before and an AI-designed molecule for idiopathic pulmonary fibrosis, the age-related lung disease with no drug that restores rapidly declining Forced Vital Capacity (FVC) - decline in lung function that is also aparent in the elderly without IPF
Table 1 summarizes these associated effects [14, 31,32,33]
Decoding toll-like receptors: recent insights and perspectives in innate immunity
Glucagon was traditionally considered counterproductive for weight management because it raises blood sugar